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Introduction
Irritable bowel syndrome (IBS) remains one of the most 
common diseases of the digestive system today. Despite all the 
achievements of the last decades, the efficacy of IBS treat-
ment remains inadequate. First of all, this is due to the fact 
that the modern therapy of IBS has primarily symptomatic 
direction. It is important to study the causes and pathogenetic 
factors of the onset and development of IBS with a view to 
their further correction, which, of course, will significantly 
improve the effectiveness of the treatment of this disease.
For a long time, the psycho-emotional component was 
considered perhaps the only cause of IBS. However, stu dies 
of the last decades have confirmed that the psycho-emo-
tional factor is sufficiently important and frequent, however, 
not the only one in the development of IBS. The role of the 
prior intestinal infection as a factor for developing the so-
called post-infectious IBS is proved. More and more studies 
are available, proving the presence of minimal inflammation 
in the intestinal mucosa in patients with IBS. The aspect of 
the relationship between intestinal microflora and IBS is in-
teresting and rapidly developing. The study of other factors 
for the development of this pathology continues.
The role of intestinal epithelial permeability in patients 
with IBS is an interesting and promising area in the study of 
IBS pathogenesis. The intestinal epithelial barrier is an im-
portant factor in intestinal homeostasis and is the first line of 
intestinal protection from external factors (microorga nisms, 
food antigens, etc.). An intercellular integration violation 
can activate a local immune response that may have an ef-
fect on the development of IBS [1–3].
The intestinal epithelial barrier is one of the largest surfa-
ces in the body that contact the external area. And it has a very 
important task: on the one hand, to ensure unimpeded ab-
sorption of water and nutrients, on the other hand, to protect 
from the harmful effects of bacterial and non-bacterial exter-
nal factors located in the intestinal cavity. Different protec-
tive factors perform this important function in the body; there 
are two levels of protection: immune (epithelial and immune 
cells) and non-immune (intestinal motility, mucus layer on 
the surface of the epithelium, water secretion) ones. All these 
components of protection normally operate in a complex and 
consistent manner, and a violation of one of them can disrupt 
the normal functioning of the intestinal barrier [1].
Among the cells of the intestinal mucosa involved in 
providing the intestinal epithelial barrier, a number of cells 
can be noted: enterocytes, mucus-producing goblet cells, 
enteroendocrine cells, Paneth cells, T- and B-lymphocytes, 
IgA-secreting plasma cells, mast cells, dendritic cells, mac-
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rophages. They closely interact with each other and provide 
the protective function of the intestinal epithelium. Certain 
receptors such as toll-like receptors, nucleotide-binding 
oligomerization domain-like receptors also perform the 
important protective function of the intestinal epithelium. 
They protect from harmful factors, co-operate with the 
bene ficial intestinal microflora, and, if necessary, affect the 
expression of antimicrobial peptides [1].
In this aspect, the apical complex on the border between 
the epithelial cells and the intestinal cavity is of particular 
interest. It provides a density of contacts between the cells 
of the intestinal epithelium. The main component of this 
complex is tight junction. Tight junctions are composed of 
transmembrane proteins (claudin, occludin, junctional ad-
hesion molecules), which interact with the proteins of adja-
cent cells. These proteins are connected to the actomyosin 
cytoskeleton filaments through scaffolding proteins (zonula 
occludens (ZO)) [1].
Tight junctions are under constant influence of vari-
ous physiological and pathological factors. Of course, the 
smooth operation of tight junction components depends to 
a large extent on the normal functioning of the entire intes-
tinal epithelial barrier.
We have considered in a simplified version the normal 
functioning of the intestinal epithelial barrier, but the ques-
tion arises about how this all is related to IBS.
To date, there is ample evidence of the correlation be-
tween increased intestinal permeability and IBS, in particu-
lar diarrhea-predominant IBS. Back in 2000, R.C. Spiller et 
al. showed increased intestinal permeability in patients with 
post-infectious form of IBS caused by a previous infection 
with Campylobacter enteritis [6].
Similar results were obtained by J.K. Marshall et al. 
(2004). Lactulose-mannitol test for intestinal permeability 
was performed in 132 patients with IBS and 86 controls. 
The result showed a significant increase in patients with IBS 
compared to controls (Mann-Whitney’s score was 118.8 vs. 
95.3, P = 0.007) [7].
In the study of S.P. Dunlop et al. (2006), it was shown 
that in patients with diarrhea, the permeability of the small 
cell epithelium was significantly increased compared to pa-
tients with constipation-predominant IBS and healthy in-
dividuals. Interestingly, in patients with IBS without prior 
intestinal infection, permeability was more affected than in 
patients with post-infection type of IBS [4].
Q. Zhou et al. in 2009 investigated the intestinal permea-
bility by means of lactulose-mannitol method in 54 patients 
with diarrhea, and 22 healthy individuals. In 39 % of patients 
with diarrhea-predominant IBS, an increased permeability 
of the intestinal epithelium was detected. The relationship 
between increased intestinal permeability and the severity of 
intestinal symptoms was an important result of this study. 
Thus, the Functional Bowel Disorder Severity Index in pa-
tients with IBS and high permeability was 100.8 ± 5.4, in 
patients with IBS and normal permeability — 51.6 ± 12.7, 
in controls — 6.1 ± 5.6. The authors of the study concluded 
that increased intestinal permeability increases visceral hy-
persensitivity in patients with IBS [5].
Interesting results were recently obtained in the study of 
Z. Mujagic et al. Small intestinal and gastroduodenal per-
meability was analyzed by various methods in patients with 
different forms of IBS as compared to controls. It was found 
that gastroduodenal permeability was increased in all forms 
of IBS. Instead, the intestinal permeability was elevated pre-
dominantly in patients with diarrhea-predominant IBS [8].
In recent years, there were obtained the results of the eva-
luation of the tight junction components in patients with IBS.
In a study by P. Cheng et al. (2015), molecular and cel-
lular mechanisms of tight junctions were evaluated using 
electron microscopy, and intestinal epithelial claudin-1 was 
detected by immunohistochemical study, western blot ana-
lysis, and fluorescence quantitative polymerase chain reac-
tion. Claudin-1 expression has been shown to be reduced in 
diarrhea-predominant IBS and elevated in IBS with consti-
pation [9]. In another study in China, the following results 
were shown: claudin-1 and -4 expression decreased in pa-
tients with IBS and diarrhea, claudin-1, -3, and -4 expres-
sion increased with constipation [10].
In the Spanish study of C. Martínez et al., the expression 
of ZO-1 in the intestinal biopsy sample was analyzed, taking 
into account the number of mast cells and clinical symp-
toms in patients with diarrhea-predominant IBS. It has been 
found that ZO-1 expression was significantly reduced in pa-
tients with diarrhea. There is also a significant correlation 
between ZO protein, mast cell activity and clinical symp-
toms in patients with IBS [11].
As already mentioned, with regard to the tight junction 
components, there is a difference in the various forms of 
IBS. In a recent study, there was no significant difference in 
the expression of occludin, claudin, and ZO in women with 
constipation-predominant IBS compared to controls [12].
In the study by N. Bertiaux-Vandaële et al., all major 
tight junction components were examined in 55 patients with 
different forms of IBS. It was found that expression of ZO-1 
and occludin was significantly reduced in patients with IBS, 
Figure 1 — Molecular components of tight junction 
(Martínez C., González-Castro A., Vicario M., 
Santos J., 2012)
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while claudin had a tendency to decrease. The study of these 
indices in different forms of IBS showed that expression of 
occludin and claudin-1 was reduced in diarrhea-predomi-
nant form and was not reduced in constipation-predominant 
and mixed form of IBS. Expression of occludin and clau-
din-1 correlated with the duration of IBS symptoms. Inte-
restingly, the expression of occludin was particularly reduced 
in patients with abdominal pain higher than 6 on the visual 
analogue scale that confirmed the relationship between the 
state of tight junction (and, consequently, intestinal per-
meability) and the severity of clinical symptoms of IBS [13].
We would like to share the results of our own research 
on the subject.
The purpose of the study was to compare the expression 
of occludin in patients with IBS and in healthy individuals.
Materials and methods
The research was conducted at the premises of the Insti-
tute of Gastroenterology of the National Academy of Medi-
cal Sciences of Ukraine. Nineteen biopsy specimens were 
evaluated: 12 — in patients with diarrhea-predominant IBS, 
7 — in healthy controls.
The study was performed using immunohistochemical 
method. As primary antibodies, rabbit polyclonal occludin 
antibodies (GeneTex, USA-Taiwan) were used at dilution of 
1 : 50. Master Polymer Plus Detection System (peroxidase), 
including DAB Chromogen (Master Diagnostica, Spain), 
was used as secondary antibodies.
During the immunohistochemical reaction, occludin was 
stained brown. To determine occludin content, quantita-
tive morphometric analysis was performed using the ImageJ 
program, which evaluated the brightness of the images in pi-
xels. In every biopsy sample, there were evaluated 10 squares 
(100 × 100 pixels), as well as minimal, maximal and mean 
brightness. The darker the image was (the more the occlusion 
was expressed), the lower the brightness value at ImageJ.
Results
Figures 2 and 3 show biopsy specimens in patients with 
IBS and in control group.
Parameters of occludin expression in comparison groups 
are shown in Tables 1 and 2.
Table 1 — Expression of occludin in biopsy samples 
of patients with IBS
Biopsy 
sample
Mean 
brightness
Minimal 
brightness
Maximal 
brightness
1 172.71 ± 1.41 149.60 ± 2.03 191.10 ± 1.70
2 175.01 ± 1.03 142.30 ± 3.39 195.90 ± 1.45
3 164.55 ± 2.38 132.40 ± 4.13 188.90 ± 1.09
4 160.87 ± 1.19 124.00 ± 2.29 187.30 ± 2.09
5 175.24 ± 1.54 146.90 ± 5.71 189.40 ± 1.24
6 165.01 ± 1.81 119.40 ± 12.46 187.80 ± 0.76
7 176.98 ± 1.18 148.30 ± 3.12 197.90 ± 1.11
8 162.55 ± 1.30 131.00 ± 2.19 187.1 ± 2.09
9 165.77 ± 0.83 139.00 ± 0.88 187.20 ± 0.90
10 162.87 ± 1.35 127.60 ± 2.67 188.80 ± 1.50
11 170.36 ± 1.83 123.20 ± 11.19 191.90 ± 1.56
12 167.69 ± 1.03 139.00 ± 2.02 189.00 ± 0.89
Mean 
value 168.30 ± 0.63 135.22 ± 0.95 190.19 ± 0.32
Figure 2 — Intestinal mucosal biopsy specimens 
in patient with IBS. Immunohistochemical analysis
Figure 3 — Intestinal mucosal biopsy specimens 
in healthy person. Immunohistochemical analysis
As can be seen from the data obtained, the brightness 
during the ImageJ evaluation in the IBS group (168.30 ± 
0.63) was significantly higher than in the control group 
(158.70 ± 1.46) (p < 0.001). Consequently, occludin ex-
pression in patients with IBS was significantly lower than in 
healthy subjects.
Table 2 — Expression of occludin in biopsy samples 
of controls
Biopsy 
sample
Mean 
brightness
Minimal 
brightness
Maximal 
brightness
1 162.16 ± 4.52 88.40 ± 11.90 193.50 ± 1.48
2 163.22 ± 4.94 104.50 ± 9.60 194.40 ± 1.73
3 156.33 ± 4.22 84.60 ± 10.03 188.50 ± 1.52
4 162.59 ± 2.56 97.80 ± 8.74 192.30 ± 1.00
5 157.52 ± 3.94 101.50 ± 7.16 185.80 ± 2.12
6 156.05 ± 2.92 89.30 ± 6.53 190.10 ± 1.33
7 153.01 ± 3.34 96.20 ± 6.96 183.70 ± 1.53
Mean 
value 158.70 ± 1.46 94.61 ± 0.87 189.75 ± 0.48
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Conclusions
1. The use of an immunohistochemistry to evaluate the 
expression of occludin in the intestinal mucosa allows us to 
evaluate the permeability of the intestinal epithelium.
2. In patients with IBS, the expression of occludin is 
significantly lower than that of healthy individuals.
Thus, one of the most important factors in the develop-
ment of IBS is the deterioration in the functioning of the 
intestinal epithelial barrier. The studies performed show a 
decrease in occludin concentrations in patients with IBS. 
Further investigations concerning this problem may be very 
important for better understanding of pathogenesis of IBS.
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Визначення міжклітинних контактів у хворих 
із синдромом подразненого кишечника
Резюме. У статті наведено аналіз літературних даних сто-
совно порушення кишкової проникності як одного з пато-
генетичних факторів синдрому подразненого кишечника. 
Детально розглянуто будову щільних контактів як важли-
вого елемента нормального функціонування кишкового 
бар’єра. Розглянуті дослідження, у яких попередньо ви-
вчали експресію компонентів щільних контактів у хворих 
із синдромом подразненого кишечника. Показанo резуль-
тати власного дослідження з оцінкою експресії оклюдину 
в пацієнтів iз синдромом подразненого кишечника. Було 
встановлено, що експресія оклюдину є нижчою у хворих 
із синдромом подразненого кишечника порівняно зі здо-
ровими особами.
Ключові слова: синдром подразненого кишечника; кишко-
ва проникність; щільні контакти; оклюдин; імуногістохіміч-
ний метод
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Определение межклеточных контактов у больных 
с синдромом раздраженного кишечника
Резюме. В статье приведен анализ литературных данных о 
нарушении кишечной проницаемости как одного из патоге-
нетических факторов синдрома раздраженного кишечника. 
Детально рассмотрено строение плотных контактов как важ-
ного элемента нормального функционирования кишечного 
барьера. Рассмотрены исследования, в которых предвари-
тельно изучали экспрессию компонентов плотных контактов 
у больных с синдромом раздраженного кишечника. Пока-
заны результаты собственного исследования с оценкой эк-
спрессии окклюдина у пациентов с синдромом раздраженно-
го кишечника. Было установлено, что экспрессия окклюдина 
ниже у больных с синдромом раздраженного кишечника по 
сравнению со здоровыми лицами.
Ключевые слова: синдром раздраженного кишечника; ки-
шечная проницаемость; плотные контакты; окклюдин; им-
муногистохимический метод
